Home
Jeffrey Eisele, Chief Development Officer: Apellis Pharmaceuticals APLS Sell · Filed 24/12/27
Trade details
- Type
- Insider sale
- Amount
- $2,084.67
- Shares · price
- 63 sh · $33.09 a share
- Held after
- 57,145 sh
- Trade date
- 24/12/23
- Filed
- 24/12/27
- Days to filing
- 4 days
Sold 0.1% of holdings
- Share of holding sold
- 0.1%
Apellis Pharmaceuticals trades, last 26 weeks
What else happened in Apellis Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/11/23~25/01/22Jeffrey Eisele's recent trades
- Jeffrey Eisele
SellApellis Pharmaceuticals
SellApellis Pharmaceuticals
APLS
$8,207
278 sh
$8,207
Filed 25/01/30
Traded 25/01/29
- Jeffrey Eisele
SellApellis Pharmaceuticals
SellApellis Pharmaceuticals
APLS
$39.3K
1,291 sh
$39.3K
Filed 25/01/23
Traded 25/01/22
- Jeffrey Eisele
SellApellis Pharmaceuticals
SellApellis Pharmaceuticals
APLS
$7,577
264 sh
$7,577
Filed 25/01/14
Traded 25/01/13
- Jeffrey Eisele
Sell10b5-1 planApellis Pharmaceuticals
Sell10b5-1 planApellis Pharmaceuticals
APLS
$63.6K
971 sh
$63.6K
Filed 24/01/31
Traded 24/01/30
- Jeffrey Eisele
Sell10b5-1 planApellis Pharmaceuticals
Sell10b5-1 planApellis Pharmaceuticals
APLS
$17.9K
279 sh
$17.9K
Filed 24/01/31
Traded 24/01/29